期刊文献+

Kazal型人类丝氨酸蛋白酶抑制因子研究现状 被引量:4

原文传递
导出
摘要 在肿瘤的生长、血管生成以及浸润和转移过程中,除了生长因子与抑癌基因突变、细胞周期改变等上游机制的参与外,蛋白酶扮演了最终共同途径的角色,并且在功能性或病理性组织重建过程中起到重要的作用。大量实验证明,
作者 迟庆 伦永志
出处 《中华临床医师杂志(电子版)》 CAS 2010年第8期117-119,共3页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献22

  • 1Aureli L,Gioia M,Cerbara I,et al.Structural bases for substrate and inhibitor recognition by matrix metalloproteinases.Curr Med Chem,2008,15(22):2192-2222.
  • 2Coussens LM,Fingleton B,Matrisian LM.Matrix metalloproteinase inhibitors and cancer:trials and tribulations.Science,2002,295(5564):2387-2392.
  • 3Steverding D,Caffrey CR,Sajid M.Cysteine proteinase inhibitors as therapy for parasitic diseases:advances in inhibitor design.Mini Rev Med Chem,2006,6(9):1025-1032.
  • 4Goerge T,Barg A,Schnaeker EM,et al.Tumor-derived matrix metalloproteinase-1 targets endothelial proteinase-activated receptor 1 promoting endothelial cell activation.Cancer Res,2006,66(15):7766-7774.
  • 5McMahon B,Kwaan HC.The plasminogen activator system and cancer.Pathophysiol Haemost Thromb,2008,36(3 /4):184-194.
  • 6Schneider A.Serine protease inhibitor kazal type 1 mutations and pancreatitis.Clin Lab Med,2005,25(1):61-78.
  • 7Whisstock JC,Bottomley SP.Molecular gymnastics:serpin structure,folding and misfolding.Curr Opin Struct Biol,2006,16(6):761-768.
  • 8Tekin S,Padua MB,Brad AM,et al.Expression and properties of recombinant ovine uterine serpin.Exp Biol Med(Maywood),2006,231(8):1313-1322.
  • 9Cohn JA,Mitchell RM,Jowell PS.The impact of cystic fibrosis and PSTI /SPINK1 gene mutations on susceptibility to chronic pancreatitis.Clin Lab Med,2005,25(1):79-100.
  • 10Chandak GR,Idris MM,Reddy DN,et al.Mutations in the pancreatic secretory trypsin inhibitor gene (PSTI/SPINK1) rather than the cationic trypsinogen gene (PRSS1) are significantly associated with tropical calcific pancreatitis.J Med Genet,2002,39(5):347-351.

同被引文献74

  • 1周游,李龄,蒋先惠.软脑膜下多处横切术的手术原理和适应证[J].功能性和立体定向神经外科杂志,1994,7(3):37-38. 被引量:3
  • 2Lopez-Otin C, Overall C M. Protease degradomies: a new challenge for proteomics. Molecular Cell Biology, 2002, 3(7): 509-519.
  • 3Clynen E, Schoofs L, Salzet M. A Review of the most important classes of serine protease inhibitors in insects and leeches. Medicinal Chemistry Reviews, 2005, 2(3): 197-206.
  • 4Zhao Y, Sun W, Zhang P, Chi H, Zhang M J, Song C Q, Ma X, Shang Y, Wang B, Hu Y, Hao Z, Huhmer A F, Meng F, L'Hemault S W, He S M, Dong M Q, Miao L. Nematode sperm maturation triggered by protease involves sperm-secreted serine protease inhibitor (Serpin). Proceedings of the National Academy of Sciences of the United States of America, 2012, 109(5): 1542-1547.
  • 5Park H J, Seong Y M, Choi J Y, Kang S, R-him H. Alzheimers disease-associated amyloid beta interacts with the human serine protease HtrA2/Omi. Neuroscience Letters, 2004, 357(1): 63-67.
  • 6Hook G, Hook V, Kindy M. The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity. Journal of Alzheimer's Disease, 2011, 26(2): 387-408.
  • 7Kim J T, Song E Y, Chung K S, Kang M A, Kim J W, Kim S J, Yeom Y I, Kim J H, Kim K H, Lee H G. Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer. Cancer, 2011, 117(12): 2608-2619.
  • 8Krowarsch D, Cierpicki T, Jelen F, Otlewski J. Canonical protein inhibitors of serine proteases. Cellular and Molecular Life Science, 2003, 60(11): 2427-2444.
  • 9Hibbetts K, Hines B, Williams D, An overview of proteinase inhibitors. Journal of Veterinary Internal Medicine, 1999, 13(4): 302-308.
  • 10Magdolen V, de Prada N A, Sperl S, Muehlenweg B, Luther T, Wilhelm O G, Magdolen U, Graeff H, Reuning U, Schmitt M. Natural and synthetic inhibitors of the tumor-associated serine protease urokinase-type plasminogen activator. Advanced in Experimental Medecine and Biology, 2000, 477:331-341.

引证文献4

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部